Fuciderm

Disclaimer: This site has been created by www.MedicAnimal.com for information purposes only. MedicAnimal is a proud retailer of Fuciderm but is not affiliated with or related to the manufacturer of Fuciderm and the contents of this site are neither sponsored or endorsed by the manufacturer of Fuciderm.

Buy Fuciderm

Introduction

Presentation

A translucent aqueous based gel containing fusidic acid 0.5 % w/w and betamethasone 0.1 % w/w (as the valerate ester) with methylparahydroxybenzoate 0.27 % w/w and propylparahydroxybenzoate 0.03 % w/w as preservatives.

Uses

For the topical treatment of surface pyoderma in the dog such as acute moist dermatitis (‘hot spots’) and intertrigo (skin fold dermatitis).
Betamethasone valerate possesses anti-inflammatory and anti-pruritic properties. Fusidic acid is an antibiotic which is active against Staphylococcus, in particular, S. intermedius, the major organism associated with pyoderma in the dog. It is also active against streptococci

Dosage & administration

For use in dogs only.
Apply a quantity of the gel to the affected area, twice daily, for a minimum period of 5 days. Treatment should continue for 48 hours after the lesion has resolved. The treatment period should not exceed 7 days. If there is no response within three days, or the condition deteriorates, the diagnosis should be re-evaluated.

Price comparison

Contra-indications, warnings, etc.

For animal treatment only.
For external use only.
Do not use in animals with hypersensitivity to any of the components. Discontinue use if hypersensitivity develops to the product.
Do not use in pregnant animals.
Do not use for the treatment of deep pyoderma as glucocorticoids are contraindicated in this condition.
Do not use where fungal infection is present.
Betamethasone valerate can be absorbed percutaneously and may cause temporary suppression of adrenal function. Prolonged treatment or the treatment of large surface areas should be avoided.
Anti-inflammatory corticosteroids, such as betamethasone valerate, are known to exert a wide range of side effects. Whilst single high doses are generally well tolerated, they may induce severe side effects in long term use and when esters possessing a long duration of action are administered. Dosage in medium to long term use should therefore generally be kept to the minimum necessary to control symptoms.
Steroids themselves, during treatment, may cause Cushingoid symptoms involving significant alteration of fat, carbohydrate, protein and mineral metabolism, e.g. redistribution of body fat, muscle weakness and wastage or osteoporosis may result. During therapy, effective doses suppress the hypothalamo-pituitreal-adrenal axis. Following cessation of treatment, symptoms of adrenal insufficiency can arise and this may render the animal unable to deal adequately with stressful situations.
Locally applied steroids may cause thinning of the skin.
Corticosteroids are not recommended for use in pregnant animals. Administration in early pregnancy may cause abortion or early parturition.
Corticosteroids may delay wound healing and the immunosuppressant action may weaken resistance to or exacerbate existing infections. In the presence of viral infections, steroids may worsen or hasten the progress of the disease.
Local steroid therapy is contraindicated in the presence of corneal ulceration.
Gastrointestinal ulceration has been reported in animals treated with corticosteroids, and gastrointestinal ulceration may be exacerbated by steroids in patients given non-steroidal anti-inflammatory drugs and in animals with spinal cord trauma. Steroids may cause enlargement of the liver (hepatomegaly) with increased serum hepatic enzymes.
Operator warnings
Corticosteroids may produce irreversible effects in the skin; they can be absorbed and may have harmful effects, especially with frequent and extensive contact or in pregnancy. Always wear single-use disposable gloves when applying this product to animals.
Wash hands after applying the product.
Keep out of the reach of children.

Pharmaceutical precautions

Do not store above 25°C. Do not refrigerate or freeze.

Packaging quantities

Tubes of 15 g and 30 g.

Further information

The dog should be prevented from licking treated lesions and so ingesting the product.
Where there is a risk of self-trauma, preventative measures, such as the use of an Elizabethan collar, should be considered.

Disclaimer

This site has been created by www.MedicAnimal.com for information purposes only. MedicAnimal is a proud retailer of Fuciderm but is not affiliated with or related to the manufacturer of Fuciderm and the contents of this site are neither sponsored or endorsed by the manufacturer of Fuciderm.